Pacific Biosciences Of California | PACB - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Agilent USD 29M 4M 2026-06
Bruker USD 17.8M 9.7M 2026-06
Danaher USD 135M 28M 2026-09
General Electric Aerospace USD 231M 265M 2026-09
Illumina USD 24M 0 2026-09
Myriad Genetics USD 4.4M 600K 2025-12
Pacific Biosciences Of California USD 1.74M 1000 2025-12
Quidel USD 5.78B 66M 2026-09
Revvity USD 20.81M 2.18M 2026-09
Roche Holding CHF 304M 7.5M 2025-06
Standard Biotools USD 5K 5K 2025-12
Thermo Fisher Scientific USD 417M 63M 2026-09
Waters USD 53M 2M 2026-09